S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors

被引:2
作者
Mandarino, Angelo [1 ]
Thiyagarajan, Swetha [1 ]
Martins, Allana C. F. [1 ]
da Silva Gomes, Roberto [1 ]
Vetter, Stefan W. [1 ]
Leclerc, Estelle [1 ]
机构
[1] North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA
关键词
S100; protein; HMGB1; pancreatic cancer; GLYCATION END-PRODUCTS; CALCIUM-BINDING PROTEIN; CELL-PROLIFERATION; EXPRESSION; RAGE; PROMOTES; INVASION; RECEPTOR; GROWTH; MIGRATION;
D O I
10.3390/biom13081175
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pancreatic cancer remains a disease that is very difficult to treat. S100 proteins are small calcium binding proteins with diverse intra- and extracellular functions that modulate different aspects of tumorigenesis, including tumor growth and metastasis. High mobility group box 1 (HMGB1) protein is a multifaceted protein that also actively influences the development and progression of tumors. In this study, we investigate the possible correlations, at the transcript level, between S100s and HMGB1 in pancreatic cancer. For this purpose, we calculated Pearson's correlations between the transcript levels of 13 cancer-related S100 genes and HMGB1 in a cDNA array containing 19 pancreatic cancer tumor samples, and in 8 human pancreatic cancer cell lines. Statistically significant positive correlations were found in 5.5% (5 out of 91) and 37.4% (34 of 91) of the possible S100/S100 or S100/HMGB1 pairs in cells and tumors, respectively. Our data suggest that many S100 proteins crosstalk in pancreatic tumors either with other members of the S100 family, or with HMGB1. These newly observed interdependencies may be used to further the characterization of pancreatic tumors based on S100 and HMGB1 transcription profiles.
引用
收藏
页数:16
相关论文
共 90 条
  • [71] S100A16 is a prognostic marker for colorectal cancer
    Sun, Xu
    Wang, Teng
    Zhang, Chun
    Ning, Kuan
    Guan, Zhang-Rui
    Chen, Shu-Xian
    Hong, Ting-Ting
    Hua, Dong
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2018, 117 (02) : 275 - 283
  • [72] S100A10 protein expression is associated with oxaliplatin sensitivity in human colorectal cancer cells
    Suzuki, Sayo
    Yamayoshi, Yasuko
    Nishimuta, Akito
    Tanigawara, Yusuke
    [J]. PROTEOME SCIENCE, 2011, 9
  • [73] Inhibition of the Receptor for Advanced Glycation End Products Enhances the Cytotoxic Effect of Gemcitabine in Murine Pancreatic Tumors
    Swami, Priyanka
    O'Connell, Kelly A.
    Thiyagarajan, Swetha
    Crawford, Ayrianne
    Patil, Prathamesh
    Radhakrishnan, Prakash
    Shin, Simon
    Caffrey, Thomas C.
    Grunkemeyer, James
    Neville, Tammi
    Vetter, Stefan W.
    Hollingsworth, Michael A.
    Leclerc, Estelle
    [J]. BIOMOLECULES, 2021, 11 (04)
  • [74] RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells
    Tabata, Takahiro
    Tsukamoto, Nobukazu
    Fooladi, Abbas Ali Imani
    Yamanaka, Sumitaka
    Furukawa, Toru
    Ishida, Masaharu
    Sato, Daisuke
    Gu, Zhaodi
    Nagase, Hiroki
    Egawa, Shinichi
    Sunamura, Makoto
    Horii, Akira
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 390 (03) : 475 - 480
  • [75] Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
    Taguchi, A
    Blood, DC
    del Toro, G
    Canet, A
    Lee, DC
    Qu, W
    Tanji, N
    Lu, Y
    Lalla, E
    Fu, CF
    Hofmann, MA
    Kislinger, T
    Ingram, M
    Lu, A
    Tanaka, H
    Hori, O
    Ogawa, S
    Stern, DM
    Schmidt, AM
    [J]. NATURE, 2000, 405 (6784) : 354 - 360
  • [76] Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion
    Tanaka, Mizuko
    Ichikawa-Tomikawa, Naoki
    Shishito, Namiko
    Nishiura, Keisuke
    Miura, Tomiko
    Hozumi, Ayumi
    Chiba, Hideki
    Yoshida, Sayaka
    Ohtake, Tohru
    Sugino, Takashi
    [J]. BMC CANCER, 2015, 15
  • [77] The Expression of S100A4 in Human Pancreatic Cancer Is Associated With Invasion
    Tsukamoto, Nobukazu
    Egawa, Shinichi
    Akada, Masanori
    Abe, Keiko
    Saiki, Yuriko
    Kaneko, Naoyuki
    Yokoyama, Satoru
    Shima, Kentaro
    Yamamura, Akihiro
    Motoi, Fuyuhiko
    Abe, Hisashi
    Hayashi, Hiroki
    Ishida, Kazuyuki
    Moriya, Takuya
    Tabata, Takahiro
    Kondo, Emiko
    Kanai, Naomi
    Gu, Zhaodi
    Sunamura, Makoto
    Unno, Michiaki
    Horii, Akira
    [J]. PANCREAS, 2013, 42 (06) : 1027 - 1033
  • [78] Expressional and Prognostic Value of S100A16 in Pancreatic Cancer Via Integrated Bioinformatics Analyses
    Tu, Gangping
    Gao, Wenzhe
    Li, Ying
    Dian, Yating
    Xue, Bingyang
    Niu, Li
    Yu, Xiao
    Zhu, Hongwei
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [79] S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin
    Wang, Lingzhi
    Yan, Wei
    Li, Xukun
    Liu, Zhihua
    Tian, Tian
    Chen, Tanxiu
    Zou, Liang
    Cui, Zhumei
    [J]. JOURNAL OF OVARIAN RESEARCH, 2019, 12 (01)
  • [80] High expression of S100A11 in pancreatic adenocarcinoma is an unfavorable prognostic marker
    Xiao, Ming-Bing
    Jiang, Feng
    Ni, Wen-Kai
    Chen, Bu-You
    Lu, Cui-Hua
    Li, Xiao-Yan
    Ni, Run-Zhou
    [J]. MEDICAL ONCOLOGY, 2012, 29 (03) : 1886 - 1891